Skip to main content
OpenTrials
Completed

NCT Number: NCT04373798

C-reactive Protein Levels Among Individuals With COVID-19

The primary objective of this multi-center study is to clarify the value of a CRP measurement for triage of patients initially presenting with light symptoms of the COVID-19 infection.

Current recommendations of management of COVID-19 include large-scale tests for virus. Such tests reveal whether an individual is infected with the virus, however, the demonstration of virus per se has no prognostic value for the ensuing course of the COVID-19 disease. Publications of possible treatments strategies increase exponentially, while evidence of triage of the affected individuals is mainly based on the level of pulmonary affection as measured by the Oxygen saturation.

To inform decision making for which patients are to be hospitalized due to risk of developing more severe affection, this study addresses the question, whether triage may be performed with the aid of a simple CRP measurement.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Coronavirus Infection Coronaviridae Infections Coronavirus Infections Infections Nidovirales Infections RNA Virus Infections Virus Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

The Parker Institute, Frederiksberg Hospital

Copenhagen, 2000, Denmark

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • A test for COVID-19 taken at the check point
  • Signed, informed consent for blood test to be drawn for the Biobank

Exclusion criteria

  • Former admission to hospital for COVID-19
  • Direct admission from check point.

Treatment and study plan

C-reactive protein

Diagnostic Test

Measurement of CRP value from blood sample taken at covid19 check point (baseline).

Primary outcomes

  1. Hospitalisation

    Time frame: within 28 days

    Admission to a hospital. Reason for admission is recorded.

Secondary outcomes

  1. Death

    Time frame: within 28 days

  2. Transfer to Intensive Care Unit

    Time frame: within 28 days

  3. Oxygen treatment during hospitalisation

    Time frame: within 28 days

Sponsors and collaborators

Lead sponsor

Henning Bliddal

Other

Registry information

Official study title

Triage Strategies Based on C-reactive Protein Levels Among Individuals With COVID-19: A Prospective Cohort Study

Important dates

Study start
2020
Primary completion
2020
Study completion
2021
First posted
May 4, 2020
Registry last updated
Aug 18, 2021

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.